Secure Payments | Trusted by Professionals | Fast Delivery

Mutant YK11 – 5mg (60 Capsules)

✔ Supports lean muscle growth
✔ Helps increase strength output
✔ Promotes firmer, denser muscle appearance

$89.99

Availability: 15 in stock

SKU MUTANTYK Category Tags , Brand:

Guaranteed Safe Checkout:

Break Through Your Genetic Muscle-Building Limits

How it works

YK-11 is among the most distinctive compounds in selective androgen receptor research.
Unlike typical non-steroidal SARMs, YK-11 possesses a steroidal backbone derived from dihydrotestosterone (DHT) while still functioning as a selective androgen receptor modulator. This hybrid structure allows it to activate anabolic signalling while influencing additional gene pathways not observed in other SARMs.

What makes it remarkable is its apparent impact on follistatin—a regulatory glycoprotein that binds and neutralises myostatin, the natural protein responsible for limiting muscle growth. By upregulating follistatin, YK-11 may indirectly suppress myostatin, enabling extended muscle cell development beyond standard anabolic signalling thresholds.

What You'll Notice

Blocks myostatin naturally

Lets muscles grow past genetic limits

Increases follistatin

The protein that neutralizes myostatin

Dense Muscle Appearance

Encourages hard, dry tissue rather than fluid retention

High Anabolic Activity

Demonstrates stronger muscle-cell differentiation than DHT analogues

Improves bone density

Boosts osteoblast production for stronger skeleton

Stack Compatibility

Complements non-steroidal SARMs through unique biochemical action

Fast-acting results

Visible changes in muscle hardness within 2 weeks

Promotes muscle differentiation

Builds actual muscle fibers, not just water

So What Exactly Is This Stuff?

YK-11’s anabolic influence leads to gradual but highly refined gains in muscle tissue.
Rather than increasing intracellular water or glycogen, it appears to promote muscle fibre differentiation—the formation of new contractile fibres that improve density and definition.
Researchers often describe the resulting tissue as “dry, hard, and mature,” reflecting structural rather than volumetric growth.

This lean-tissue effect also contributes to improved vascular visibility and muscular definition, making YK-11 a frequent focus in studies exploring muscle-quality enhancement over bulk size.

Understanding the Myostatin Pathway

Myostatin acts as a biological “growth regulator,” limiting how much skeletal muscle tissue the body can build. Individuals with lower myostatin levels naturally exhibit greater muscle potential. YK-11’s mechanism centres on increasing follistatin, which binds to and inhibits myostatin, reducing that genetic limitation.

Laboratory studies indicate that when follistatin production was blocked, YK-11’s anabolic effects diminished—supporting the theory that follistatin induction is its primary driver of action. This sets YK-11 apart from other SARMs, which rely solely on androgen receptor activation to stimulate muscle protein synthesis.

Performance and Strength Observations

Experimental data suggest that YK-11 enhances endurance and muscular stamina by delaying fatigue under sustained load. Its impact on raw strength output is moderate but steady, indicating efficiency in muscular adaptation rather than explosive power.
Some hypotheses note that extreme suppression of myostatin could alter muscle fibre composition toward slower-twitch endurance fibres, though this effect has primarily been observed in preclinical models.

Bone and Structural Support

YK-11 has demonstrated strong osteogenic potential in laboratory environments, increasing the activity of osteoblasts—the cells responsible for bone formation. This aligns with interest in its use for research on bone density restoration and musculoskeletal resilience.

Improved bone strength complements muscular adaptation, reducing structural strain under increased physical demand.

Stacking Potential

YK-11’s distinct biological pathway makes it an effective candidate for combination studies:

  • YK-11 + RAD-140 – Explores dual pathways: androgen receptor activation plus myostatin modulation
  • YK-11 + LGD-4033 – Examines mass-building synergy via complementary receptor selectivity
  • YK-11 + Cardarine (GW-501516) – Investigates concurrent endurance and fat-oxidation effects
  • YK-11 + Ostarine (MK-2866) – Evaluates lean-gain support with reduced suppression profiles

These research pairings aim to study additive or synergistic effects across distinct molecular targets.

Considerations in Laboratory Settings

Across studies, LGD-4033 has generally been well-tolerated, with mild, transient events such as fatigue or headache occasionally noted. No major hepatic or cardiovascular toxicity was reported at research dosages. Ongoing studies continue to monitor long-term biomarker data and dose-response safety curves.

Dosage Guidelines

Beginners​

5mg

Daily

Intermediate

5–10 mg

daily, split twice per day

Advanced

10–15mg

daily, divided doses

Timing:

YK-11 displays an active window of approximately 6–12 hours, making twice-daily administration common for stable concentrations.

Duration:

Research periods typically last 4–6 weeks, with some extending to 8 weeks in advanced settings. Shorter cycles are favoured due to YK-11’s steroidal backbone and increased metabolic load compared to non-steroidal SARMs.

Response Timeline

Early indicators—enhanced muscle tone and firmness—often appear within 10–14 days, with progressive changes in muscle density throughout the study duration.

What's In The Bottle

Disclaimer: The information provided is for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment. Always consult your physician or a qualified healthcare professional regarding any medical concerns or before using any products. Do not ignore or delay medical advice based on content seen here. We are not liable for how any research compounds are used.

Related Products

Scroll to Top